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Abstract
Due to the slow growth rate and pathogenicity of mycobacteria, enumeration by traditional reference methods like colony
counting is notoriously time-consuming, inconvenient and biohazardous. Thus, novel methods that rapidly and reliably
quantify mycobacteria are warranted in experimental models to facilitate basic research, development of vaccines and anti-
mycobacterial drugs. In this study we have developed quantitative polymerase chain reaction (qPCR) assays for
simultaneous quantification of mycobacterial and host DNA in infected human macrophage cultures and in mouse tissues.
The qPCR method cannot discriminate live from dead bacteria and found a 10- to 100-fold excess of mycobacterial
genomes, relative to colony formation. However, good linear correlations were observed between viable colony counts and
qPCR results from infected macrophage cultures (Pearson correlation coefficient [r] for M. tuberculosis=0.82; M. a.
avium=0.95; M. a. paratuberculosis=0.91). Regression models that predict colony counts from qPCR data in infected
macrophages were validated empirically and showed a high degree of agreement with observed counts. Similar correlation
results were also obtained in liver and spleen homogenates of M. a. avium infected mice, although the correlations were
distinct for the early phase (,day 9 post-infection) and later phase ($day 20 post-infection) liver r=0.94 and r=0.91; spleen
r=0.91 and r=0.87, respectively. Interestingly, in the mouse model the number of live bacteria as determined by colony
counts constituted a much higher proportion of the total genomic qPCR count in the early phase (geometric mean ratio of
0.37 and 0.34 in spleen and liver, respectively), as compared to later phase of infection (geometric mean ratio of 0.01 in both
spleen and liver). Overall, qPCR methods offer advantages in biosafety, time-saving, assay range and reproducibility
compared to colony counting. Additionally, the duplex format allows enumeration of bacteria per host cell, an advantage in
experiments where variable cell death can give misleading colony counts.
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Introduction
Rapid methods for enumerating slow-growing mycobacteria like
M. tuberculosis, M. avium avium and M. avium paratuberculosis in cell
cultures or infected tissues are needed both in human and
veterinary medicine. Traditionally, quantification of mycobacteria
is done by seeding serial dilutions of bacterial suspensions on
suitable media such as Middlebrook 7H10 agar or Lowenstein
Jensen followed by counting colony-forming units (CFU).
However, this method is hampered by the long generation time
and the tendency of mycobacteria to aggregate, resulting in
multiple founders of a single colony and an underestimation of the
correct number of bacteria. Typically, the time required for visible
colonies to appear on 7H10 agar is 2–3 weeks for M. tuberculosis
and M. a. avium, while it takes about 4–8 weeks for M. a.
paratuberculosis. In addition, plating enough dilutions to make sure
the results can be reliably counted is a tedious task that gives piles
of plates with biohazardous bacteria. A further disadvantage of the
colony counting method is that it cannot be reliably conducted on
frozen samples, which may be both more practical and desirable in
several research settings. Another method often used for
quantification of mycobacteria is the radiometric measurement
of the growth index (GI) using the BACTEC system. Though
more rapid than colony counting, it still requires 1–4 days. In
addition, the GI is not only dependent on the initial bacterial
number but is also influenced by the replication characteristics of
the particular bacterium and the metabolic rate. Hence, the GI of
different mycobacterial species is not directly comparable, and
bacteria grown under different experimental conditions may
display different levels of dormancy making GI comparisons
problematic.
We have previously validated a real-time quantitative PCR
assay (qPCR) for detection of mycobacteria in a diagnostic setting
[1]. Several other studies have also described distinct qPCR assays
for detection and quantification of specific mycobacteria in a
clinical setting and PCR based methods are now well established
for mycobacterial diagnostics in both human and veterinary
medicine. However, to our knowledge surprisingly few studies
have directly compared qPCR with CFU counting in research
settings [2,3]. In this paper, we have refined our qPCR assay into a
duplex format that allows simultaneous quantification of both
mycobacterial and mammalian host DNA (human or mice). We
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traditional CFU counting in infected macrophage cultures with or
without HIV co-infection. Mycobacterial infection in the context
of HIV is a clinical problem. It is therefore important that
experimental methods may accommodate for this scenario. We
also compared the performance of the qPCR assay to traditional
CFU counting in mouse tissue.
Materials and Methods
Ethics Statement
This research used peripheral blood from 15 anonymous HIV
negative blood donors obtained from the Bloodbank at Bergen
Hospital Trust, Haukeland University Hospital, Bergen, Norway.
Blood donors give a general consent for the use of their blood for
research at the time of donation; as such no further informed
consent was required as all data were analyzed anonymously.
All experiments involving mice were kept to a minimum and
performed according to protocols approved by the local Animal
Care Committee (ref. 40/05, St Olavs hospital, Norway).
Mycobacterial strains
Frozen aliquots with predetermined CFU of the clinical isolate
S72/89 (serovar 4) of M. a. avium obtained from the blood of an
AIDS patient (kindly provided by Dr. Sven Hoffner, Dept. of
Bacteriology/TB section, Swedish Institute for Infectious disease
Control, Solna, Sweden) and of the human clinical isolate Linda of
M. a. paratuberculosis (kindly provided by Dr. Ingrid Olsen, Dept. of
Animal Health, National Veterinary Institute, Oslo, Norway) were
used in this study. The M. tuberculosis H37Rv strain (ATCC
no. 27294, kind gift from Dr Harleen Grewal, The Gade Institute,
University of Bergen, Bergen, Norway) was grown in Middlebrook
7H9 broth (Difco/Becton Dickinson) with OADC enrichment
(Difco/BD) and 0.05%Tween 80, passed five times through a
sterile syringe with a 29G needle to disrupt bacterial clumps before
aliquots were frozen at 280uC and CFU determined by plating
appropriate dilutions on Middlebrook 7H10 agar (Difco/BD).
Virulent M. a. avium clone 104 expressing firefly luciferase (kind gift
from David R. Sherman [4]) was cultured in Middlebrook 7H9
broth supplemented with glycerol, Tween 80 and ADC.
Human monocyte-derived macrophages
Peripheral blood mononuclear cells (PBMC) were isolated from
buffy coats of 15 anonymous HIV negative blood donors (from the
Bloodbank at Bergen Hospital Trust, Haukeland University
Hospital, Bergen, Norway) by centrifugation on a lymphoprep
(AXIS-SHIELD PoC AS, Norway) density gradient as previously
described [5]. For differentiation into monocyte-derived macro-
phages (MDM), PBMCs were cultured in RPMI 1640 supple-
mented with glutamine and 20% pooled heat-inactivated human
serum (HS) for 5 days, followed by washing and further
maturation for 2 more days in RPMI/10% HS as previously
described [6].
In vitro infection of macrophages
Seven days post isolation half of the MDMs from each donor
were infected with HIV-1 BaL at a viral titer corresponding to
5 ng/ml of p24 in cell culture medium and incubated overnight at
37uC in 5%CO2. Culture medium was changed the next day and
the HIV infection was further allowed to establish itself for seven
days before mycobacterial infection. Two weeks old MDMs with
or without HIV infection were incubated overnight at 37uCi n
5%CO2 with the specified mycobacteria at an estimated
multiplicity of infection (MOI) of 5 CFU per cell. In order to
remove extra-cellular bacteria, cells were washed three times with
PBS. (The assessment of the effect of HIV on mycobacterial
growth has been published separately [6]). Cells infected with M.
tuberculosis H37Rv or M. a. avium (S72/89) were cultured for one
week, while cells infected with M. a. paratuberculosis were cultured
for 14 days. Infected cells from at least three parallel wells of each
donor were lysed in sterile water at specified time points and
appropriate serial dilutions seeded on Middlebrook 7H10 agar
plates in, at least, duplicates. Aliquots of the same lysates were also
stored in cryotubes containing 250 ml of acid washed glass beads
#106 mm in size (Sigma-Aldrich, Norway) at 280uC for later
DNA extraction and use in qPCR assays.
In vivo mouse infection
Infection was done as described previously [7] using log phase
M. a. avium clone 104 expressing firefly luciferase (1–5610
7
bacteria/mouse) in 0.5 ml PBS, by peritoneal injection into 8–12
weeks old C56Bl/6 mice (Bomholdt, Denmark). The inoculum
was plated on 7H10 agar plates for determination of the injected
dose. Organs (spleen and liver) were harvested from 4–5 mice at
given times post infection and homogenized in PBS/0.05%
Tween80 using an Omni tissue homogenizer with a 10695 mm
saw tooth stainless steel generator probe (Omni International, GA,
US). Organ homogenates were plated in serial dilutions for colony
counting, or quickly frozen in liquid nitrogen for 10–15 min and
stored at 280uC until use, usually within 1 to 3 weeks, for
quantification by qPCR.
DNA extraction for qPCR
From in vitro infected macrophages. Mycobacteria were
inactivated by boiling cryotubes containing lysate and micro glass
beads in a water bath for 20 min. Subsequently, the mycobacteria
were disrupted mechanically by bead beating using a Ribolyser
(Hybaid, UK) at max speed (6.5 m/s) for 45 s. The resulting crude
mycobacterial DNA extract was used directly in the qPCR assay
without further purification.
From mouse tissues. Frozen samples of organ homogenates
were thawed on ice and then aliquoted into tubes containing about
0.5 g of 0.5 mm glass beads (VWR International, USA).
Mycobacteria were inactivated by heating at 95uC in a heat
block for 20 min. Mycobacteria were further disrupted
mechanically by bead-beating using Precellys 24 bench-top lysis
and homogenization equipment (Bertin Technologies, France) 3
times at a speed of 6700 rpm for 30 s. DNA extraction was done
using the MasterPure Complete DNA and RNA Purification Kit
from EPICENTRE Biotechnologies, USA, according to the
manufacturer’s protocol for extraction of total DNA from fluids.
Quantitative real-time PCR
From in vitro infected macrophages. A duplex quantita-
tive real-time PCR assay was set up for the human b-globulin gene
and the mycobacterial heat shock protein 65 gene GroEL2 using the
QuantiTect Multiplex PCR Kit (Cat. No 204543, QIAGEN,West
Sussex, UK) as per the manufacturer’s instructions for TaqMan
Probes with a final concentration of all primers and probes of
0,4 mM and 0,2 mM, respectively. For the human b-globulin gene,
a 150 bp long segment was amplified using the primers BG-F (59-
TGCCTATCAGAAAGTGGTGGCT-39) and BG-R (59-GCTC-
AAGGCCCTTCATAATATCC-39) and the probe BG-TAQ
(59TGGCTAATGCCCTGGCCCACAA-39) as previously described
[8]. However, due to the need for multiplexing and optimal
performance, a TaqMan-MGB probe tagged with FAM was used
instead of the FAM and TAMRA tagged TaqMan probe originally
described [8]. For the mycobacterial GroEL2 gene, a 103 bp long
qPCR versus CFU for Quantification of Mycobacteria
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AGGCGATGGACAAGGT-39) and TB 12 (59-CTTGTCGAAC-
CGCATACCCT-39) with the VIC tagged TaqMan-MGB probe
MycoPr1 (59-AACGAGGGCGTCATCACCGTCG-39) as previ-
ously published by our group [1]. The qPCR was performed with a
7500 Fast-Real-Time System (Applied Biosystems, Foster City, CA,
USA) with the following thermal cycling conditions: 95uC for
15 min to activate HotStartTaq DNA Polymerase, followed by 40
cycles of 94uC for 1 min and 60uC for 1 min. Standard curves were
included in each qPCR run and were generated from known
dilutions of commercially available genomic human male DNA
(Applied Biosystems) and genomic M. tuberculosis H37Rv DNA
available through TB Vaccine Testing and Research Materials
Contract (Mycobacteria Research Laboratories, Colorado State
University, Colorado, USA). The amount of DNA in each human
or mycobacterial DNA standard was converted to number of
human targets or mycobacterial targets by simply dividing with the
estimated molecular weight of the haploid human genome (3.3 pg)
or mycobacterial genome (4.8 fg) as each amplicon is a single-copy
element in the respective genome.
From mouse tissues. Similarly, a duplex quantitative PCR
was performed on DNA extracts from infected mouse tissue
homogenates. The mycobacterial heat shock protein 65 gene
GroEL2 was amplified with the same primers and probe as above
using the TaqMan Universal PCR Master Mix (Applied
Biosystems, CA, USA). A 62 bp long segment of the murine
peptidylprolyl isomerase A (ppia) gene was also amplified in the duplex
reaction. The custom-designed primers for ppia were as follows;
forward, 59-GAGCCACTCACCTGATGCTTA-39, reverse, 59-
GGCAATGAAAATGCTACCACCTT-39 and the FAM-tagged
MGB probe 59-ACCTGTCAGCATAGCTT-39. All primers and
probes were used at a concentration of 8 mM and 4 mM,
respectively. The qPCR was performed in the Applied
Biosystems StepOnePlus
TM Real Time PCR system, as follows:
precycling steps of 50uC for 2 min and then 95uC for 10 min
followed by 40 cycles of 95uC for 1 min and 60uC for 1 min.
Standard curves were included in each qPCR run and were
generated from known dilutions of mouse genomic DNA (The
Jackson Laboratory, Maine, USA) and genomic Mycobacterium sp
(LGC Standards, VA, USA).
Statistical analysis
All data were analyzed using the SPSS version 15.0 statistical
software package for Windows (SPSS Inc., Chicago, IL, USA).
Data from in vitro infected macrophages. All the paired
CFU and qPCR values were log transformed. Each data set from
macrophage cell cultures infected with the different mycobacterial
strainswasthensplitinto twosubsets usingthe random caseselection
option in SPSS set at 50%. All data from one of the subsets for each
mycobacterial strain were used to calculate the Pearson correlation
coefficient for investigation of an association and regressed to
generate a prediction model for log(CFU) based on log(qPCR).
Subsequently, the performance of each prediction model was tested
in the appropriate second data subset by performing an agreement
analysis of the predicted log(CFU) versus the observed log(CFU)
using the Bland and Altman approach [9].
Data from mouse tissues. The paired CFU and qPCR data
were log transformed and the Pearson correlation coefficient
calculated. As the distribution of CFU to qPCR ratios were
skewed, the ratios were log transformed to render the data
normally distributed. The difference between the mean log
transformed ratios of early versus later time-points was analyzed
by an independent samples t-test and the result reported as the
back transformed geometric means.
Results
Assay Performance: Dynamic range and Reliability of
qPCR assays
Key performance characteristics of the mycobacterial assay are
summarized in Table 1. In preliminary experiments using ten-fold
serial dilutions of genomic M. tuberculosis H37Rv DNA with known
concentration, we established that the qPCR for mycobacterial
GroEL2 gene has a sensitivity of detection corresponding to one
mycobacterial genome (approximately 5 fg of genomic DNA) and
a very wide dynamic range from 10
0–10
7 targets per reaction.
The number of bacteria and human cells usually used in
macrophage virulence assays are in the range of 10
5–10
7
mycobacteria and 10
4–10
6 adherent human macrophages per well.
Under our experimental conditions, this corresponded to an
intermediate range of 500 to 40 000 mycobacterial GroEL2 targets
per reaction (final PCR mixture volume of 20 ml per reaction) and a
low range of 50 to 1000 host b-globulin targets per reaction. Hence,
the variability in the assays was examined over these ranges using
serial dilutions of mycobacterial and human DNA, respectively.
The intra- and inter-run variability was assessed as described by
Rutledge and Cote [10] by evaluating the standard deviation in
the threshold cycle (CT) from independent qPCR runs of replicate
standard DNA dilution series. The fluorescence threshold was set
Table 1. Key Characteristics of the Mycobacterial GroEL2 gene qPCR Assay.
Factor Mycobacterial assay
Dynamic Range 10
0–10
7 Target Molecules
Sensitivity of Detection 1 Target copy (5 fg of mycobacterial DNA)
Mean slope of 5 replicate standard curves (±26SD) 23.37 (±0.12)
PCR Efficiency (±26SD) 98.0% (±5.0%)
Coefficient of Determination (R
2)
RMean R
2 of 5 replicate standard curves (626SD) 0.991 (±0.008)
Intra-run Variation
REstimated Range in % of Target Molecules from 5 replicate runs ±3.55% to ±6.25%.
Inter-run Variation
RMean % of Target Molecules (range) from 5 replicate runs 4.80% (±0.07 to ±15.35)
doi:10.1371/journal.pone.0034931.t001
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data from independent qPCR. Overall, in five independent qPCR
runs, the standard deviation in CT of replicate amplifications for
mycobacterial GroEL2 ranged from 0.001 to 0.206 cycles, with a
mean of 0.068 cycles. Assuming a near 100% qPCR efficiency (as
indicated by the standard curve in Figure 1), this corresponds to
inter-assay variation in quantified GroEL2 target molecules ranging
from 60.07% to 615.35% with an average of 64.80%. Taking
the average standard deviation in CT observed in each individual
run, the intra-run variation in terms of percent quantified GroEL2
target molecules ranged from 63.55% to 66.25%. For the human
b-globulin assay, the inter- and intra assay variability was also
evaluated in five independent runs. In terms of quantified human
b-globulin molecules the inter assay variability ranged from
61.19% to 661.78% with an average of 616.30%, and the
intra-run variation ranged form 69.95% to 622.55%. Variability
assessment was also done for the mouse ppia assay used on mouse
tissues. Overall, in three independent experiments, results were
reproducible with inter- and intra assay variability ranging from
60% to 619% with an average of 69.5%, and 60% to 69%
(average=64.5%), respectively.
Duplex qPCR assay compared to singleplex qPCR
reactions
We wanted to develop a duplex qPCR for quantitative analysis
of mycobacterial numbers in mammalian host cells and tissues
(human or mice). The simultaneous quantification of host DNA is
advantageous both as a control for PCR inhibitors when
quantifying mycobacteria, and for exact determination of the
number of host cells in a sample. This is of special interest in
research settings like macrophage virulence assays or for anti-
mycobacterial drug testing in cell cultures where there is a need to
normalize the mycobacterial growth relative to the number of host
cells present in different experimental conditions.
The duplex qPCR was set up using a commercially available
pre-optimized master mix for multiplexing. The performance of
the primer-probe sets used was tested in individual singleplex
reactions before combining them in a duplex format to ensure that
the individual singleplex PCR reactions performed optimally. By
evaluating the efficiency of the individual PCR reactions, as
judged by the slope of the standard curves for each singleplex
target, we established that the reaction conditions were optimal as
all PCR reactions displayed similar and near 100% efficiency
(Figure 1). We next confirmed that the duplex format worked
equally well as the individual singleplex qPCR assays by
comparing the performance of the duplex qPCR with the
singleplex PCR reactions in three simulated situations for the
human assay (Table 2): 1) Excess of human DNA, 2) Near equal
amount of human and mycobacterial DNA, and 3) Excess of
mycobacterial DNA. Thus, the duplex qPCR assay is robust with
respect to varying ratios of bacterial to host DNA.
No interference of HIV infection on the correlation of
mycobacterial qPCR and CFU in infected macrophage
cell cultures
It is biologically plausible that HIV components may interfere
with the qPCR assay, especially the viral reverse transcriptase or
protease as we used a simple DNA extraction method that resulted
in crude cell lysate without further purification. To formally rule out
this possibility, an initial dot plot analysis of mycobacterial qPCR
versus CFU stratified for HIV infection was done. Similar linear
correlations were found for qPCR and CFU in HIV negative and
HIV infected macrophage cell cultures (data not shown). For the
subsequent analysis, the data from HIV negative and HIV infected
cultures were pooled for each of the three mycobacteria tested.
A strong linear association between qPCR and CFU in
infected macrophage cell cultures allows estimation of
CFU from qPCR data
The conventional colony counting method is a measure of live
bacteria, while the qPCR assay measures genomic load, which
Figure 1. Standard Curves for the Mycobacterial, Human and Mouse targets used. Typical standard curves for the qPCR assays generated
from serial dilutions of genomic M. tuberculosis H37Rv with slope 23,255 (A.), human genomic DNA with slope 23,141(B.) and mouse genomic DNA
with slope 23,225(C.). The PCR reactions display similar efficiency (E) of near 100% as given by the equation E=10
(21/slope)21.
doi:10.1371/journal.pone.0034931.g001
Table 2. Comparison of Duplex qPCR with corresponding Singleplex qPCR in three simulated situations.
1. Excess human DNA
Approximate No. of Targets Duplex qPCR Mean CT (±SD) Singleplex qPCR Mean CT (±SD)
Human:12120 24.90 (±0.01) 25.02 (±0.05)
Mycobacterial:78 36.18 (±0.02) 35.91(±0.07)
2. Near equal amount of human and mycobacterial DNA
Approximate No. of Targets Duplex qPCR Mean CT (±SD) Singleplex qPCR Mean CT (±SD)
Human:808 29.06 (±0.09) 28.91(±0.06)
Mycobacterial:788 32.62 (±0.09) 32.50 (±0.13)
3. Excess mycobacterial DNA
Approximate No. of Targets Duplex qPCR Mean CT (±SD) Singleplex qPCR Mean CT (±SD)
Human:80 32.33 (±0.35) 32.22(±0.05)
Mycobacterial:78800 26.12 (±0.01) 26.08(±0.06)
CT=Treshold cycle.
doi:10.1371/journal.pone.0034931.t002
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DNA. To directly compare the two methods for bacterial
quantification, growth of M. tuberculosis, M. a. avium, and M. a.
paratuberculosis in infected human macrophages was monitored over
time by colony counting and by qPCR. As shown in Figure 2,
colony counts gave values consistently below the qPCR counts.
Overall, both methods generated similar, and almost parallel,
growth curves for the three mycobacteria tested. This suggests a
strong linear correlation between the two methods. Notably, the
geometric mean CFU to qPCR ratio remained relatively stable
during the culture period for a given species: M. tuberculosis=0.02;
M. a. avium=0.39; M. a. paratuberculosis=0.02.
To further investigate the feasibility of predicting colony counts
based on qPCR results, the dataset for infected macrophage cell
cultures of each mycobacterial strain was randomly split into two
subsets; one training subset and one test subset. Using only the
training subset for each strain, the data was analyzed for a linear
association between CFU and qPCR. The number of biological
culture wells with experimentally paired colony count and qPCR
result is indicated by n*.A strong positive linearcorrelation between
the log transformed paired CFU (log(CFU)) and qPCR (log(qPCR))
values was found with a Pearson correlation coefficient (r) for M.
tuberculosis r=0.82 (p=5610
215; n*=58), M. a. avium r=0.95
(p=1610
233;n * = 6 4 )a n dM. a. paratuberculosis r=0.91
(p=1610
220; n*=51). Subsequently, a linear regression model
was generated for each strain in order to enable a prediction of
log(CFU)fromlog(qPCR). Figure3 depictstheindividualregression
models for each strain along with the 95% prediction limits for an
individual measurement. The regression equations are provided in
Table 3. Hence, using the regression model for M. a. avium one may
predict that for a given log(qPCR) value, for instance 3.39 (the
mean), the log(CFU) will on average be 2.99 with a 95% confidence
interval for an individual log(CFU) ranging from 2.66 to 3.32.
As CFU and qPCR give results in different units and measure
related, but biologically different entities, we used the regression
models from the training subsets of each strain to predict the
log(CFU) for all measured values of log(qPCR) in the test subsets.
Subsequently, the agreement between the predicted log(CFU) and
the paired actually measured log(CFU) was analyzed to asses the
value of the regression models. The analysis was done using the
Bland and Altman approach [9] and is presented graphically in
Figure 4. The predictions tended to slightly underestimate the
actual log(CFU). For M. tuberculosis, the mean difference (95% CI)
between the predicted and the actual log(CFU) for an individual
measurement was 20.06 (20.69 to 0.57), while for M. a. avium it
was 20.006 (20.32 to 0.31) and for M. a. paratuberculosis it was
20.04 (20.63 to 0.55). Expressed as the ratio of geometric means
of predicted to actual CFU of an individual measurement this
approximates into a mean ratio (95% CI) for M. tuberculosis of 0.9
(0.2 to 3.7), while for M. a. avium it is 1.0 (0.5 to 2.0) and for M. a.
paratuberculosis it is 0.9 (0.2 to 3.5). Since a perfect agreement would
give a ratio of exactly 1.0, the overall level of agreement seems
satisfactory, especially considering the inherent variability of CFU
due to mycobacterial clumping.
Strong, but distinct time dependent linear correlations
between CFU and qPCR in tissue homogenates from M.
a. avium infected mice
Pathogenic mycobacteria are capable of persisting in immuno-
competent hosts causing a chronic, latent infection. It is well
established that tissue macrophages are the primary host cells for
mycobacteria and initiate the innate immune response [11].
Furthermore, in mice infected by M. tuberculosis it has been shown
that naı ¨ve T-cell activation takes place in the regional lymph nodes
by day 9 post-infection and that the acquired immune response in
lung tissue is established by about day 20 post-infection which is
accompanied by an increased ability of the host to control M.
tuberculosis growth [12]. A similar immune response to M. a. avium
Figure 2. Mycobacterial growth in infected Macrophages as
measured by colony counting and qPCR. Growth of M. tuberculosis
(A), M. a. avium (B), and M. a. paratuberculosis (C) in in vitro infected
human macrophages as monitored over time by colony counting (solid
line) and qPCR (dashed line). Error bars represent 95% confidence
intervals.
doi:10.1371/journal.pone.0034931.g002
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mycobacterial infection of macrophage cell cultures, it is expected
that the in vivo host immune response in infected animals may
affect the correlation between viable bacilli counts (CFU) and total
genome counts (qPCR) over time with the onset of acquired
immunity. Comparing CFU counts, which reflect viable bacteria,
to total genome counts of mycobacteria in animal models may
thus, be useful for the understanding of the pathogenesis and host-
pathogen equilibrium [3].
We quantified M.a. avium in the spleen and liver of infected mice
over time by both CFU and qPCR (Figure 5, panel A and B). As
evident in Figure 5, the quantification curves by the two methods
are virtually parallel and similar in shape prior to day 9 post-
infection similar to the observations in macrophage cultures. The
curves are also parallel from day 20 and onwards post-infection.
This suggests linear but distinct correlations between CFU and
qPCR during these time periods, i.e. one correlation prior to the
onset of the acquired immune response (before day 9 post-infection)
and a different linear correlation once the acquired immune
response is established (after day 20 post-infection). However,
between day 9 and day 20 post-infection there is a sharp rise in total
genome counts (qPCR) indicating active mycobacterial replication
while the viable counts (CFU) rises less sharply suggesting an
increased ability of the host to control or kill M. a. avium. This
observation is in line with the view that the development of the
acquired immune response changes the underlying relationship of
CFU and qPCR, with the consequent loss of linear correlation
during the time period of immunological transition.
The CFU to qPCR ratio decreased significantly between early
(day 2 and 8) versus later (day 20, 23, 34 and 110) time points in
both spleen (from geometric mean ratio of 0.37 to 0.01) and liver
(from geometric mean ratio of 0.34 to 0.01) with a mean fold
difference in ratios (95% CI; p-value) of 48 (18–128; p,0.0001)
and 26 (12–56; p,0.0001), respectively (Figure 5, panel C and D).
Interestingly, in the early phase of infection the initial geometric
Figure 3. Regression models for predicting log(CFU) from
log(qPCR) in macrophage cell cultures. Regression models for
predicting log(CFU) from log(qPCR) for M. tuberculosis, M. a. avium and
M. a. paratuberculosis in in vitro infected macrophage cell cultures
derived from the data in respective training subset for each
mycobacteria. Regression line in the middle with 95% prediction limits
for an individual log(CFU) on each side. As it is customary to do multiple
replicate CFU measurements from the same biological sample, note
that the 95% prediction limits for an individual log(CFU) are wider apart
than the corresponding 95% prediction limits for the predicted mean
log(CFU) (not shown) for multiple measurements. Hence, the regressed
point estimate for the predicted log(CFU) will be the same, but using
the models as presented will tend to give wider and in fact more
conservative estimates of the confidence intervals if used to predict the
mean log(CFU) of multiple measurements as compared to the
individual log(CFU).
doi:10.1371/journal.pone.0034931.g003
Table 3. Experimentally determined regression equations for
prediction of log(CFU) from log(qPCR) in infected
macrophage cultures.
Mycobacteria Regression equation
M. tuberculosis (H37Rv) Predicted log(CFU)=0.6626log(qPCR)20.311
M. a. avium (S72/89, serovar 4) Predicted log(CFU)=0.9156log(qPCR)20.117
M. a. paratuberculosis (Linda) Predicted log(CFU)=1.2666log(qPCR)22.661
doi:10.1371/journal.pone.0034931.t003
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34931Figure 4. Agreement analysis of predicted log(CFU) versus actual measured log(CFU) in macrophage cell cultures. Top panel: Dot
plot of predicted log(CFU) from qPCR data versus actual measured log(CFU) in macrophage cultures with the line of equality (black) for M.
tuberculosis, M. a. avium and M.a. paratuberculosis, respectively. Ideally, with a perfect agreement between the two methods all point should exactly
align themselves along the line of equality (y=x).
Middle panel: Bland and Altman plot of the paired difference between the two methods against the mean value generated by the methods (i.e. the
best estimate of the true value) with the mean difference (dashed line in the middle) and 95% limits of agreement (black lines). A paired difference of
zero indicates perfect agreement.
Bottom panel: Histogram of the paired difference between the two methods for the respective mycobacteria. The paired differences display a
normal distribution around means which are close to zero, indicating a relative good agreement between the methods without any overt tendencies
of either over- or underestimation.
doi:10.1371/journal.pone.0034931.g004
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was similar to the geometric mean ratio observed in macrophage
cell cultures for M. a.avium (0.39). This suggests a similar
correlation between CFU and qPCR count in macrophage
cultures and tissue in the absence of an acquired immune
response. Furthermore, the drop in mean ratio over time in
infected mice coincides with the transition from the early to the
later phase of infection and the onset of adaptive immunity. The
decreased CFU to qPCR ratio in the later phase of infection in
both tissue types suggests relatively stable pathogen-host equilib-
rium with low rate of bacterial replication. However, it should be
noted that the qPCR method will quantify bacterial DNA and
may thus overestimate the viable tissue bacterial load due to
possible accumulation of dormant bacteria or mycobacterial DNA
from dead bacteria over time. On the other hand, the CFU
method could further underestimate the bacterial load in chronic
infections as it may fail to detect dormant forms of mycobacteria
persisting in the tissues that are inefficient in forming colonies on
agar, but that will be enumerated by qPCR [13].
As the relationship between CFU and qPCR counts changed
over time in the mouse model, we analyzed data from the early
phase (,day 9 post-infection) and the later phase ($day 20 post-
infection) separately (Figure 6). The number of independent
murine samples with experimentally paired colony count and
qPCR result is denoted by n
#. We found strong, but distinct
positive linear correlations between log(CFU) and log(qPCR) for
the early and later phase of infection in both spleen (r=0.91;
p=0.004; n
#=7 and r=0.87; p,0.001; n
#=15, respectively)
and liver (r=0.94; p=0.006; n
#=6 and r=0.91;p,0.001;
n
#=10, respectively)
Figure 5. Quantification of M.a.avium in infected mouse tissue as measured by colony counting and qPCR. Experimentally determined
quantification curves of M. a. avium in infected mouse spleen (A) and liver (B) as measured by viable CFU counts (solid line) and total qPCR counts
(dashed line). Values are means of log(CFU) (#) or log(qPCR) (%) from 3 to 4 mice at each time point. Analysis of the mean CFU to qPCR ratio (m)i n
spleen (C) and liver (D) shows that the geometric mean ratio decreases significantly between early and later time points.* p-value for difference in
mean log(CFU/qPCR) for Early vs. Later time points in spleen p,0.0001 and liver p,0.0001. All error bars are 6 26SEM.
doi:10.1371/journal.pone.0034931.g005
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In this study we have established a rapid and reliable duplex
real-time quantitative PCR method that allows the simultaneous
quantification of mycobacterial and mammalian host DNA
(human or mice). The duplex qPCR method proved to be robust
with respect to varying ratios of bacterial to host DNA and HIV
co-infection did not interfere with the performance of the assay.
We used the duplex approach throughout the paper (Figure 2
through 6) with the simultaneous quantification of host DNA
serving as a useful integral control for PCR inhibitors when
quantifying mycobacteria. In the present study, we did not need to
utilize the determined number of host cells to normalize
mycobacterial counts. Because paired CFU and qPCR measure-
ments were performed on samples from the same experimental
well or tissue homogenate, it is appropriate to assume that the
number of host cells is constant for a given pair. Hence, the actual
number of measured host cells is redundant for the presented
correlational analysis of the biological paired CFU to qPCR.
However, the need to normalize for the number of host cells may
be a prerequisite to conduct an appropriate data analysis when
comparing mycobacterial counts under different experimental
conditions to account for differences in growth and death of host
cells. This is not normally done using CFU quantification of
mycobacteria and thus represents a clear advantage of the duplex
qPCR method that we have utilized in a previously published
report [6].
Real-time polymerase chain reaction based quantification of
DNA is generally regarded as a very sensitive and reliable
technique, although the precision may decrease at very low target
numbers [14,15]. All our qPCR assays displayed optimal reaction
conditions as evidenced by their efficiencies of near 100%. The
precision level of the mycobacterial qPCR assay was good and
within acceptable limits [10]. Although the human assay displayed
higher variation, it was probably caused by the low target range
used in the assay as PCR in general is especially prone to variation
between replicates below 1000 targets per reaction [10].
A critical step for successful qPCR is the DNA extraction. Slow-
growing mycobacteria like M. tuberculosis have a unique gram
positive-like cell wall covered by a waxy lipid rich envelope which
makes DNA extraction more difficult, but several methods for
mycobacterial DNA extraction from various sources have been
described (reviewed in [16] and [17]). A number of studies have
advocated the usefulness and simplicity of bead beating for DNA
extraction from mycobacteria [18,19,20,21]. We successfully
employed a rapid DNA extraction protocol based on simple
boiling and mechanical bead beating for DNA extraction from
infected macrophage cell cultures. However, this simple protocol
proved inadequate for tissue samples yielding inconsistent results
due to the presence of PCR inhibitors. Therefore, the DNA
extraction had to be further optimized by including a commercial
kit to ensure inhibitor-free DNA extracts from tissue samples.
Some DNA loss may be inevitable during extraction resulting in
underestimation of the DNA content and thus tissue bacterial
load. However, the total DNA concentration (ng/g tissue)
measured after extraction was quite similar for different samples
of the same tissue type, but varied between tissues (higher for
spleen than for liver, data not shown).
In this paper, we demonstrated that our mycobacterial qPCR
assay works for M. tuberculosis, M. a.avium and M. a.paratubeculosis.
However, we acknowledge that a wider specificity test, using DNA
from other mycobacterial species, has not been performed for the
reported assay. Thus, it should be noted that a standard nucleotide
BLAST search (NCBI database) using the 103 base pair long
mycobacterial target indicates that the assay may have limitations
and will probably not work for some mycobacteria such as M.
leprae and M. ulcerans due to single base pair mismatches between
the target and primers or probe used.
Other studies have also described the relationship between CFU
counts and qPCR counts for mycobacteria in infected cell cultures
[2] and tissue [2,3]. However, to our knowledge no study has so far
analyzed whether qPCR data can be used to predict actual CFU
counts. The observed CFU counts in this study were 1 to 2 orders
of magnitude below the qPCR counts, which is similar to findings
by Lewin et al. [2]. Like us, Lewin et al. also used a quantitative
TaqMan-PCR based approach to enumerate mycobacteria in
infected tissue and compared it to CFU counts. Interestingly, they
found that CFU counts of bacilli Calmette-Gue `rin (BCG) were 1–
2 log below the qPCR counts in tissues from infected guinea pigs.
There may be several explanations for this ranging from biological
to technological. Bacterial aggregation would probably underes-
timate the number of viable bacteria quantified by colony
counting whereas qPCR, on the other hand, cannot discriminate
dead from live bacteria. It is also plausible that qPCR, which is
Figure 6. Correlation between colony counts and qPCR in
M.a.avium infected mouse tissue. The linear relationships are similar
in spleen (A) and liver (B), but distinct for the early (#, solid line) and
later phase of infection (%, dashed line).
doi:10.1371/journal.pone.0034931.g006
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method as compared to colony counting. Thus, keeping in mind
that CFU and qPCR measure related, but biologically distinct
entities, a lack of perfect agreement between the observed CFU
counts and the CFU predicted from qPCR data is not surprising.
The overall agreement between CFU and qPCR observed for the
mycobacterial strains tested in macrophage cell cultures was good,
and the qPCR method represents an attractive alternative for
rapid and reliable quantification of mycobacteria in such settings.
Furthermore, our results also show that there are strong linear
correlations between CFU and qPCR in mouse tissue before day 9
post-infection prior to the onset of the acquired immune response
similar to the observations in macrophage cultures and also from
day 20 post-infection and onwards when the acquired immune
response is established. However, during the development of the
acquired immune response between day 9 and day 20, there is a
sharp rise in total DNA counts (qPCR) indicating active
mycobacterial replication while the viable counts (CFU) rises less
sharply suggesting an increased ability of the host to control or kill
mycobacteria. This observation is also reflected in the steep fall in
the ratio of viable to total bacteria between day 9 and day 20 post
mycobacterial infection (Figure 5, panels C and D). Hence, it
seems that in vivo the host immune response may modulate the
underlying relationship between total mycobacterial counts and
live mycobacterial counts over time and thus affect the correlation
between CFU and qPCR. Therefore, isolated interpretation of
qPCR data in an animal model must be done with caution;
keeping in mind that qPCR represents a total count of both live
and dead bacteria and that the proportion of viable bacteria may
vary over time.
To conclude, we have shown that the technical difficulties of
enumerating mycobacteria by traditional colony counts in
eukaryotic cell cultures and tissue may be overcome by using
qPCR. The qPCR method provides results rapidly which is
especially useful in many research settings and circumvents the
problems caused by bacterial aggregates. It has the added benefit
of a wide dynamic range and offers a more practical and safer
assay setup than the CFU method. Also, our analysis shows that
the qPCR method may replace CFU for measurement of
mycobacterial growth in eukaryotic cell cultures and it represents
a valuable tool for enumerating mycobacteria in animal models.
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